Search Results - A. I.  Stukan

Features of ovarian steroidogenesis and endometrial hypertrophy during adjuvant therapy with tamoxifen in premenopausal patients with hormone-dependent breast cancer by A. Yu. Goryainova, A. I. Stukan, A. I. Trofimenko, A. A. Meshcheryakov

Connect to this object online.

Significance and possible causes of hormone receptor expression loss in metastatic breast cancer. Phenotypic evolution of luminal <i>BRCA1</i>-associated breast cancer to triple ne... by A. I.  Stukan, Z. K.  Khachmamuk, V. V. Antipova, A. V. Dzagashtokova

Connect to this object online.

Causes of resistance to PARP inhibitors and ways to overcome it. Case report of aggressive <i>BRCA</i>-related breast cancer by A. I. Stukan, A. Yu. Goryainova, S. V. Sharov, O. A. Goncharova, Z. K. Khachmamuk, V. V. Durov

Connect to this object online.

Tumor immune microenvironment and apoptotic markers in breast cancer patients carrying <I>BRCA1</I> gene mutations by A. I. Stukan, A. Yu. Goryainova, O. Yu. Chukhray, S. D. Maksimenko, E. N. Imyanitov, S. V. Sharov, Z. K. Khachmamuk

Connect to this object online.

Clinical and prognostic characteristics of <I>BRCA1/2</I>-associated breast cancer depending on the type of mutation: estrogen signaling pathway and secondary tumors by A. I. Stukan, A. Yu. Goryainova, R. A. Murashko, Z. K. Khachmamuk, O. Yu. Chukhray, S. D. Maksimenko, O. A. Goncharova, E. N. Imyanitov, V. A. Porkhanov

Connect to this object online.

Predictive and prognostic features of early and locally advanced <i>PIK3CA</i>-mutated luminal HER2-negative breast cancer by A. I. Stukan, T. Yu. Semiglazova, S. I. Kutukova, V. A. Porkhanov, V. N. Bodnya, E. N. Imyanitov, V. V. Antipova, Z. K. Khachmamuk, O. Yu. Chukhray, S. D. Maksimenko

Connect to this object online.